Washington University in St Louis:製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C9290)
◆英語タイトル:Washington University in St Louis - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9290
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:63
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Washington University in St Louis (WUSTL), a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range of traditional and interdisciplinary fields. It provides degree programs in the areas of law, engineering, education, business and international affairs, medicine, public health, and others. The university’s schools include School of Engineering & Applied Science, Sam Fox School of Design and Visual Arts, George Warren Brown School of Social Work, and others. WUSTL is headquartered in St. Louis, Missouri, the US.

Washington University in St Louis – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Washington University in St Louis, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Pfizer Enters into Agreement with Washington University in St. Louis 13
GenVec Enters into Agreement with Washington University in St. Louis 14
MaxCyte Enters into Agreement with Washington University in St Louis 15
Turing Pharma Enters into Partnership with Washington University 16
Johnson & Johnson Innovation Enters into Research Agreement with Washington University 17
GenVec Enters into Agreement with Washington University at St. Louis 18
Licensing Agreements 19
Q BioMed to Expand Option Agreement with Washington University 19
Disarm Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 20
Canopy Biosciences Enters into Licensing Agreement with Washington University in St. Louis and Johns Hopkins University 21
Precision Virologics Enters into Licensing Agreement with Washington University 22
Accuronix Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 23
ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 24
Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 25
ChromaDex Amends Licensing Agreement With Washington University For Nicotinamide Riboside 26
Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 27
Washington University in St Louis – Key Competitors 28
Washington University in St Louis – Key Employees 29
Washington University in St Louis – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Government and Public Interest 31
Nov 01, 2018: Orion Research Foundation grants million euros for research in 2019 31
Oct 15, 2018: New child maltreatment research center launched with $6.5 million NIH grant 33
Oct 04, 2018: NIH funds specialized centers for child maltreatment research 34
Aug 02, 2018: Role of cell group behavior in cancer target of $1.9 million award 35
Jun 28, 2018: Kuehner commits $15 million to fund personalized medicine research 36
Jun 11, 2018: $14 million to fund research aimed at reducing childhood obesity 37
May 23, 2018: Foundation for Anesthesia Education and Research Awards $1.4 million in Grants 39
Apr 26, 2018: Noninvasive brain tumor biopsy on the horizon 42
Feb 27, 2018: Cure Alzheimer’s Fund Issued more than $15 Million in Research Grants in 2017 44
Feb 27, 2018: Engineer develops enabling technology for emerging gene therapies 45
Nov 02, 2017: Lung Cancer Research Foundation Awards $1.6 Million in Research Grants 47
Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 49
Sep 25, 2017: Human antibodies from dengue patients can effectively treat Zika infection in mice 50
Sep 25, 2017: Antibody protects against both Zika and dengue, mouse study shows 52
Sep 20, 2017: Newly ID’d role of major Alzheimer’s gene suggests possible therapeutic target 54
Jul 17, 2017: Top Cancer Research Facilities Nationwide Fueled With $1.2 Million In New Slate Of Grants 56
Apr 27, 2017: Stem cells edited to fight arthritis 57
Mar 13, 2017: University Of Utah Engineers Use CRISPR Technology To Prevent Tissue Damage And Resulting Chronic Pain 59
Clinical Trials 60
Oct 26, 2017: NIH study identifies new targets for anti-malaria drugs 60
Other Significant Developments 61
Sep 04, 2018: Focused delivery for brain cancers 61
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
Washington University in St Louis, Pharmaceuticals & Healthcare, Key Facts 2
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Washington University in St Louis, Deals By Therapy Area, 2012 to YTD 2018 9
Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pfizer Enters into Agreement with Washington University in St. Louis 13
GenVec Enters into Agreement with Washington University in St. Louis 14
MaxCyte Enters into Agreement with Washington University in St Louis 15
Turing Pharma Enters into Partnership with Washington University 16
Johnson & Johnson Innovation Enters into Research Agreement with Washington University 17
GenVec Enters into Agreement with Washington University at St. Louis 18
Q BioMed to Expand Option Agreement with Washington University 19
Disarm Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 20
Canopy Biosciences Enters into Licensing Agreement with Washington University in St. Louis and Johns Hopkins University 21
Precision Virologics Enters into Licensing Agreement with Washington University 22
Accuronix Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 23
ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 24
Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 25
ChromaDex Amends Licensing Agreement With Washington University For Nicotinamide Riboside 26
Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 27
Washington University in St Louis, Key Competitors 28
Washington University in St Louis, Key Employees 29
Washington University in St Louis, Subsidiaries 30

List of Figures
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Washington University in St Louis:製薬・医療:M&Aディール及び事業提携情報(Washington University in St Louis - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆